List view / Grid view
In this interview, Kyle Haraldsen, Chief Technology Officer of Lyndra Therapeutics, explores how the drug delivery landscape is evolving to increase focus on patient centricity and sustainability through development of long-acting, oral-delivery technologies.
Newron Pharmaceuticals and Lyndra Therapeutics’ have announced positive data from key clinical trials in schizophrenia and schizoaffective disorder.
A jury has said that Johnson & Johnson must pay $8 billion in the case over male breast growth linked to Risperdal.
Women who take certain antipsychotic medications and continue the use of these medications through pregnancy may be at increased risk for gestational diabetes...
